UNSW Sydney Achieves Unprecedented Success at Cardiovascular Research Awards!
It's a monumental moment for cardiovascular research as UNSW Sydney academics have swept three out of four prestigious awards at the 2025 Cardiovascular Research Network (CVRN) Ministerial Awards. These annual accolades celebrate groundbreaking contributions to tackling cardiovascular diseases, a group of conditions that also encompass diabetes, stroke, and kidney disease. This year, the spotlight shone brightly on UNSW for their life-changing advancements.
But here's where it gets truly remarkable:
Conjoint Professor Anthony Rodgers received the highest honor, the Ministerial Award for Cardiovascular Research Excellence, recognizing his lifelong dedication to pioneering new treatments and improving global health outcomes in cardiovascular disease. His work has already made a significant impact, and this award is a testament to decades of tireless effort.
See AlsoIran's Missile Strikes on Gulf States: A Middle East Expert Explains the StrategyStarmer appoints Antonia Romeo as head of UK civil serviceSecret to Inner Ear Cell Death: How TMC1/2 Regulators Could Harm HearingUnveiling the Brain's Secrets: New Myelin Maps Revolutionize Nerve Disorder ResearchScientia Associate Professor Thanh Nho Do was celebrated as a Rising Star for his world-leading innovations in bio-robotics, specifically in the realm of cardiac care. His work promises to revolutionize how we approach heart disease treatment.
Dr Yashutosh Joshi also earned the PhD Rising Star award for his crucial discoveries in donor heart preservation, aiming to significantly boost the success rates of heart transplants.
These incredible achievements were formally recognized by the NSW Minister for Medical Research, the Hon. David Harris, highlighting the state's commitment to fostering cutting-edge medical innovation.
A Lifetime Dedicated to Fighting Heart Disease: The Legacy of Professor Anthony Rodgers
Professor Rodgers, affiliated with The George Institute for Global Health and UNSW Medicine & Health, has been a driving force in cardiovascular research for over 30 years. His commitment extends beyond scientific discovery to actively reducing global health inequalities. A shining example of his impact is the development of a low-dose triple combination pill for hypertension. This innovative therapy, which progressed from a mere concept to a life-saving medicine, has been shown to reduce the risk of a secondary stroke by an astounding 40%. In a landmark achievement for 2025, this therapy secured approval from the US Food and Drug Administration (FDA) and was added to the World Health Organisation's Essential Medicines List. Professor Rodgers humbly emphasized that research is a collective endeavor, stating, "Research is always a team sport, especially when tackling big, complex challenges, and this award belongs to every team member, past and present, who has contributed to our shared efforts." He further noted that while FDA approval and WHO inclusion were significant milestones, the real work of ensuring global access to this treatment is just beginning.
And this is the part most people miss... the future of heart care is being built with robots!
Scientia Associate Professor Thanh Nho Do, from UNSW Engineering's School of Biomedical Engineering, is at the forefront of transforming cardiac care through bio-robotics. He leads the acclaimed UNSW Medical Robotics Lab, where he's pioneering advancements in soft robotics and cardiac devices. These innovations are paving the way for treatments that are not only less invasive but also more precise and cost-effective. Imagine robots that can 3D-print living materials inside the body to repair damaged organs, or ultra-thin catheters that can navigate deep into the brain to clear dangerous clots! Professor Do expressed his honor, stating, "This award is a great achievement for me and my team. It recognises our ambitious, high-impact research to develop next-generation soft robotic tools for safer, better treatment for doctors and patients." Under his guidance, UNSW has solidified its global leadership in bio-robotics, producing technologies like an external bionic heart sleeve that assists failing hearts without direct blood contact, significantly reducing infection risks. They've also developed a world-first soft robotic artificial heart that mimics natural heart motion, crucial for testing new devices and improving patient selection. Professor Do's vision is clear: "My hope is that these bio-robotic technologies will become part of everyday care and help people with stroke, heart valve disease and heart failure live better, longer lives."
Boosting the Odds for Life-Saving Heart Transplants
Dr Yashutosh Joshi, from the Victor Chang Cardiac Research Institute, is making waves in improving the success of heart transplants. His PhD research focused on optimizing donor heart preservation to increase both the quantity and quality of organs available. His groundbreaking work identified critical time points that influence recipient survival. Furthermore, Dr Joshi discovered that blood thinners and a unique compound called Hi1a, derived from spider venom, could dramatically enhance the protection of donor hearts, thereby improving transplantation outcomes. Dr Joshi is now continuing his vital work as a cardiothoracic surgery trainee at Westmead Hospital.
What do you think about the potential of bio-robotics in medicine? Are you excited or concerned about these advancements? Share your thoughts below!
